Apellis Pharmaceuticals Statistics
Total Valuation
APLS has a market cap or net worth of $4.61 billion. The enterprise value is $4.39 billion.
| Market Cap | 4.61B |
| Enterprise Value | 4.39B |
Important Dates
The next confirmed earnings date is Thursday, August 1, 2024, before market open.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
APLS has 121.37 million shares outstanding. The number of shares has increased by 7.98% in one year.
| Shares Outstanding | 121.37M |
| Shares Change (YoY) | +7.98% |
| Shares Change (QoQ) | +1.42% |
| Owned by Insiders (%) | 14.32% |
| Owned by Institutions (%) | 94.47% |
| Float | 81.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.80 |
| Forward PS | 4.92 |
| PB Ratio | 17.28 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.77, with a Debt / Equity ratio of 0.41.
| Current Ratio | 3.77 |
| Quick Ratio | 2.76 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.31 |
Financial Efficiency
Return on equity (ROE) is -160.70% and return on invested capital (ROIC) is -107.53%.
| Return on Equity (ROE) | -160.70% |
| Return on Assets (ROA) | -49.80% |
| Return on Capital (ROIC) | -107.53% |
| Revenue Per Employee | $746,538 |
| Profits Per Employee | -$594,406 |
| Employee Count | 702 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 0.57 |
Taxes
In the past 12 months, APLS has paid $2.02 million in taxes.
| Income Tax | 2.02M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.20% in the last 52 weeks. The beta is 0.87, so APLS's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | -6.20% |
| 50-Day Moving Average | 40.18 |
| 200-Day Moving Average | 52.15 |
| Relative Strength Index (RSI) | 44.83 |
| Average Volume (20 Days) | 1,590,652 |
Short Selling Information
The latest short interest is 14.81 million, so 12.21% of the outstanding shares have been sold short.
| Short Interest | 14.81M |
| Short Previous Month | 13.90M |
| Short % of Shares Out | 12.21% |
| Short % of Float | 18.13% |
| Short Ratio (days to cover) | 11.15 |
Income Statement
In the last 12 months, APLS had revenue of $524.07 million and -$417.27 million in losses. Loss per share was -$3.45.
| Revenue | 524.07M |
| Gross Profit | 453.16M |
| Operating Income | -404.13M |
| Pretax Income | -415.25M |
| Net Income | -417.27M |
| EBITDA | -384.48M |
| EBIT | -386.23M |
| Loss Per Share | -$3.45 |
Balance Sheet
The company has $327.03 million in cash and $109.14 million in debt, giving a net cash position of $217.89 million or $1.80 per share.
| Cash & Cash Equivalents | 327.03M |
| Total Debt | 109.14M |
| Net Cash | 217.89M |
| Net Cash Per Share | $1.80 |
| Equity (Book Value) | 266.68M |
| Book Value Per Share | 2.20 |
| Working Capital | 596.14M |
Cash Flow
In the last 12 months, operating cash flow was -$550.10 million and capital expenditures -$708,000, giving a free cash flow of -$550.81 million.
| Operating Cash Flow | -550.10M |
| Capital Expenditures | -708,000 |
| Free Cash Flow | -550.81M |
| FCF Per Share | -$4.48 |
Margins
Gross margin is 86.47%, with operating and profit margins of -77.11% and -79.62%.
| Gross Margin | 86.47% |
| Operating Margin | -77.11% |
| Pretax Margin | -79.24% |
| Profit Margin | -79.62% |
| EBITDA Margin | -73.37% |
| EBIT Margin | -73.70% |
| FCF Margin | -105.10% |
Dividends & Yields
APLS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.98% |
| Shareholder Yield | -7.98% |
| Earnings Yield | -9.05% |
| FCF Yield | -11.95% |
Analyst Forecast
The average price target for APLS is $73.06, which is 92.36% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $73.06 |
| Price Target Difference | 92.36% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 40.26% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
APLS has an Altman Z-Score of -0.04 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.04 |
| Piotroski F-Score | 2 |